Thrombin-antithrombin complex and the prothrombin fragment in arterial and venous blood of patients with peripheral arterial disease

Vasa - Journal of Vascular Diseases

Volumn 32, Issue 4, 2003, Pages 193-197

  Hering, Johannes ^a   Amann, B ^a   Angelkort, B ^a   Rottmann, M ^a  

^a KLINIKUM DORTMUND   (Germany)

Author keywords

Activation of coagulation; Blood sampling techniques; Peripheral artery occlusive disease (PAD); Prothrombin fragment (F1+F2); Thrombin antithrombin complex (TAT)

Indexed keywords

PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTERIAL BLOOD; ARTERY DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CUBITAL VEIN; DISEASE COURSE; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PUNCTURE; VEIN; VENOUS BLOOD;

EID: 0344441237     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.32.4.193     Document Type: Article

References (26)

1. Angelkort B, Amann B, Lawall H. Hemorheology and hemostasis in vascular disease. A pathophysiological review. Clin Hem and Micro 2002; 26: 145.
2. Behringwerke AG Marburg. Enzygnost© D-Dimer micro-Enzym-immunoassay zur Bestimmung des humanen Fibrinabbauprodukts D-Dimer. 1994.
3. Blanke H, Praetorius G, Leschke M, Seitz R, Egbring R, Strauer BE. Die Bedeutung des Thrombin-Antithrombin-III-Komplexes in der Diagnostik der Lungenembolie und der tiefen Beinvenenthrombose - Vergleich mit Fibrinopeptid A, Plätchenfaktor 4 und ß-Thromboglobin. Klin Wochenschr 1987; 65: 757.
4. Bruhn HD, Conard J, Manucci M, Monteagudo J, Pelzer H, Reverter JC, Samama M, Tripodi A, Wagner C. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination. Thromb Haemost 1992; 68: 413.
5. Dahl OE, Johnsen H, Kierulf P, Molnar I, Ro JS, Vinje A, Mowinckel P. Intrapulmonary thrombin generation and its relation to monomethylmethacrylate plasma levels during hip arthroplasty. Acta Anasthaesoil Scand 1992; 36: 331.
6. Demers C, Ginsberg JS, Johnston M, Brill-Edwards P, Panju A. D-dimer and thrombin antithrombin III complexes in patients with clinically suspected pulmonary embolism. Thromb Haemost 1992; 67: 408.
7. Diquelou A, Lemozy S, Dupouy B, Boneu B, Sakariassen K, Cadroy Y. Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenetic surface. Blood 1994; 84: 2206.
8. Giannitsis E, Siemens HJ, Mitusch R, Tettenborn I, Wiegand U, Schmucker G, Sheikzadeh A, Stierle U. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrogen in patients with coronary atherosclerosis. Int J Cardiol 1999; 68: 269.
9. Haynes SR, Allardyce W, Cowan B, Tansey P. Accuracy of coagulation studies performed on blood samples obtained from arterial cannalue. Br J Anaesth 1992; 69: 599.
10. Herren T, Sticker H, Haeberti A, Do DD, Straub PW. Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation 1994; 90: 2679.
11. Herren T, Bartsch P, Haeberli A, Straub PW. Increased thrombin-antithrombin III complexes after 1 h of physical exercise. J Appl Physiol 1992; 73: 2499.
12. Hoek JA, Sturk A, ten Cate JW, Lamping RJ, Berends F, Borm JJ. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. Clin Chem 1988; 34: 2058.
13. Jung F, Kiesewetter H, Roggenkamp HG, Nüttgens HP, Ringelstein EB, Gerhards M, Kotitschke G, Wenzel E, Zeller H. Bestimmung der Referenzbereiche rheologischer Parameter. Studie an 653 zufällig ausgewählten Probanden im Kreis Aachen. Klin Wochenschr 1986; 64: 375.
14. Jung F, Wappler M, Nüttgens HP, Kiesewetter H, Wolf S, Müller G. Zur Methodik der Videokapillarmikroskopie. Bestimmung geometrischer und dynamischer Messparameter. Biomed Technik 1987; 32: 204.
15. Miller GJ, Bauer KA, Barzegar S, Foley AJ, Mitchell JP, Cooper JA, Rosenberg RD. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost 1995; 73: 82.
16. Özsoylu S. The comparison of the coagulation factors in arterial and venous blood. Acta Haemat 1969; 41: 303.
17. Peltonen S, Lassila R, Rossi P, Salenius JP, Lepäntalo M. Blood coagulation and fibrinolysis activation during sudden arterial occlusion of lower extrimities - an association with ischemia and patient outcome. Thromb Haemost 1995; 74: 1442.
18. Pelzer H, Schwarz A, Stüber W. Determination of human prothrombin activation fragment F1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153.
19. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101.
20. Rabiet MJ, Blashill A, Furie B, Furie BC. Prothrombin Fragment 1.2.3, a Major Product of Prothrombin Activation in Human Plasma. Journal of Biological Chemistry 1986; 261: 13210.
21. Seitz R, Egbring R, Wagner C, Dati F. Thrombin-Antithrombin-III-Komples (TAT). Ein Marker für intravasale Gerinnungsaktivierung. Internist 1990; 31: 69.
22. Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies if the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombi-antithrombin complex. Blood 1982; 59: 1086.
23. Waerden van der BL. Mathematische Statistik. Springer-Verlag 1971; 264 und 345.
24. Witt I, Beeser H, Müller-Berghaus G. Minimalanforderungen zur Gewinnung von Citratplasma für hämostaseologische Analysen. Lab med 1995; 19: 143.
25. Woller T, Lawall H, Amann B, Angelkort B. Comparison of haemostatic parameters in arterial and venous blood from patients with peripheral arterial occlusive disease. VASA 1999; 28: 10.
26. Woodburn KR, Lowe GDO, Rumley A, Love J, Pollock JG. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol 1995; 14: 346.